Asymchem Laboratories Tianjin Co. Ltd. (OTC: ASLTY)
|
|
---|---|
Pricing data not available |
Open: | $ n/a | Volume: | n/a | |
---|---|---|---|---|
High: | $ n/a | Yield(%) | n/a | |
Low: | $ n/a | P/E Ratio (ttm): | n/a | |
Dividend ($): | n/a | Market Cap ($): | n/a | |
EPS ($) | n/a | Shares Out: | n/a |
% Price Change (last 4 weeks): | -13.73 |
---|---|
% Price Change (last 13 weeks): | -21.38 |
% Price Change (last 26 weeks): | -46.28 |
% Price Change (last 52 weeks): | -46.51 |
% Price Change (year to date): | -48.17 |
Return on Equity (%): | 13.58 |
---|---|
Return on Assets (%): | 11.65 |
Return on Invested Capital (%): | 16.68 |
Gross Profit Margin (%): | 49.05 |
---|---|
Net Profit Margin (%): | 29.27 |
Operating Profit Margin (%): | 28.58 |
50-day Moving Average: | $n/a |
---|---|
200-day Moving Average: | $n/a |
Avg. Daily Vol. (last 50 days): | n/a |
Avg. Daily Vol. (last 200 days): | n/a |
52-wk high: | $n/a |
52-wk low: | $n/a |
Bid: | $n/a |
Ask: | $n/a |
Asymchem Laboratories (Tianjin) Co., Ltd. engages in the research and development, and production of intermediates, and active pharmaceutical ingredients. Its business scopes include small molecule contract development and manufacturing organization (CDMO), and emerging service businesses. Its Small Molecule CDMO business provides process development and analysis, clinical drug production, new drug application and approval services, and current good manufacturing practice commercial production services. Its Emerging Service business covers chemical macromolecules, formulations, biosynthesis technology, biological macromolecules, and clinical research services. The company was founded by Hao Hong on October 7, 1998 and is headquartered in Tianjin, China.
|
Asymchem Laboratories Tianjin Co. Ltd.
71 7th Street Tianjin Economic & Tech Dev Zone Tianjin TI 300457 Phone: 86.22.66389560 Fax: 86.22.66252777 http://www.asymchem.com.cn |
Earnings (1year) ($): | n/a |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 3.33 |
Cash Flow ($): | 7.06 |
Price/Earnings (x): | 8.11 |
---|---|
Price/Sales (x): | 3.86 |
Price/Book (x): | 1.75 |
Price/Cash Flow (x): | 7.98 |
Quick Ratio (x): | 6.33 |
---|---|
Current Ratio (x): | 6.86 |
LT Debt/Equity (x): | 0.61 |
Total Debt/Equity (x): | 3.27 |